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Abstract 
 
Background/Aim. Based on numerous studies in animals, 
the most prominent toxic effects of decabrominated di-
phenyl ether (BDE-209) are observed in the liver, thyroid 
hormone homeostasis, reproductive and nervous systems. 
BDE-209 exhibits its toxic effects partly through the aryl 
hydrocarbon (Ah) receptor and consequent induction of 
hepatic microsomal enzymes. The aim of this study was to 
assess the hepatotoxic effect vs target tissue dose of BDE-
209 in the subacutely orally exposed Wistar rats. Methods. 
Effects were examined on male Wistar rats, weighing 200–
240 g, exposed to doses of 1,000, 2,000 or 4,000 mg BDE-
209/kg body weight (bw)/day by gavage during 28 days. 
Animals were treated according to the decision of the Eth-
ics Committee of the Military Medical Academy, No 9667-
1/2011. Evaluation of the hepatotoxic effect was based on: 
relative liver weight water and food intake, biochemical pa-
rameters of liver function [aspartate amino transferase 
(AST), alanine aminotransferase (ALT), alkaline phos-
phatase (ALP), gama glutamyl transferase (γ-GT)], and oxi-
dative stress parameters in liver homogenates [malondialde-
hiyde (MDA), superoxide dismutase (SOD), -SH] and mor-
phological and pathohistological changes in the liver. For 
the assessment of internal dose – response relationship, 
lower confidence limit of Benchmark dose (BMDL) of 5% 
or 10% i.e. BMDL5 or BMDL10, were calculated using 
PROAST software. Results. After the application of 1,000, 
2,000 or 4,000 mg BDE-209/kg bw/day, the concentrations 
of BDE-209 measured in liver were 0.269, 0.569 and 0.859 
mg/kg of liver wet weight, (ww) respectively. Internal doses 
correlated with external (r = 0.972; p < 0.05) according to 
equation: internal dose (mg BDE-209/kg of liver ww) = 
0.0002  external dose (mg/kg bw/day) + 0.0622. Hepato-
toxicity was demonstrated based on significant increase in 
AST and γ-GT activities and the degree of histopathological 
changes. The lowest BMDL5 of 0.07228 mg BDE-209/kg 
of liver ww, correlating to external dose of 39 mg/kg/day, 
indicated the increase of AST activity as the most sensitive 
biomarker of BDE-209 hepatotoxicity in subacutely ex-
posed rats. Conclusion. The results of the present work 
add up to the issue of BDE-209 toxicity profile with a focus 
on relationship between internal dose and hepatotoxicity. 
Critical internal dose for the effect on AST of 0.07 mg/kg 
of liver ww, corresponding to external dose of 39 
mg/kg/day, is the lowest dose ever observed among the 
studies on BDE-209 hepatotoxicity. For the persistent sub-
stances with low absorption rate such as BDE-209, critical 
effect based on internal dose in majority of cases is consid-
ered as more precisely defined than the effect established 
based on external dose, particularly. 
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Apstrakt 
 
Uvod/Cilj. Prema podacima iz brojnih studija na životi-
njama, dekabromovani difeniletar (BDE-209) najznačajnije 
toksične efekte ispoljava na jetri, homeostazi hormona štita-
ste žlezde, reproduktivnom i nervnom sistemu. BDE-209 
ispoljava toksične efekte delom preko receptora za aromati-
čne ugljovodonike (Ah) i posledične indukcije mikrozomal-
nih enzima jetre. Cilj rada bio je procena hepatotoksičnog 
efekta u odnosu na dozu BDE-209 u ciljnom tkivu kod su-
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bakutno oralno eksponovanih Wistar pacova. Metode. Efekti 
su ispitivani na mužjacima Wistar pacova, mase 200–240 g, 
koji su putem oralne sonde primali doze od 1 000, 2 000 ili 4 
000 mg BDE-209/kg telesne mase (tm) dan, tokom 28 dana. 
Životinje su tretirane u skladu sa odlukom Etičkog komiteta 
Vojnomedicinske akademije u Beogradu br. 9667-1/2011. 
Procena hepatotoksičnih efekata bazirana je na merenju rela-
tivne mase jetre, unosa vode i hrane, biohemijskih parametara 
funkcije jetre [aspartat aminotransferaza (AST), alanin amino-
transferaza (ALT), alkalna fosfataza (ALP), gama glutamil 
transferaza (γ-GT)], parametara oksidativnog stresa u homo-
genatima jetre [malondialdehid (MDA), superoksid dizmutaza 
(SOD), -SH)] i morfoloških i histoloških promena na jetri. Za 
procenu odnosa interna doza – odgovor izračunavana je do-
nja granica pouzdanosti granične Benchmark doze (BMDL) 
od 5% (BMDL5) ili 10% (BMDL10) primenom PROAST sof-
tvera. Rezultati. Koncentracije BDE-209 iznosile su 0,269, 
0,569 i 0,859 mg/kg jetre nakon aplikacije 1 000, 2 000, od-
nosno 4 000 mg BDE-209/kg tm/dan. Interna doza u našoj 
studiji korelisala je sa eksternom dozom prema jednačini: in-
terna doza (mg BDE-209/kg jetre) = 0,0002  eksterna doza 
(mg/kg tm/dan) + 0,0622 (r = 0,972; p < 0,05). Hepatotok-
sičnost je potvrđena na osnovu nalaza o povećanju aktivnosti 
enzima AST i γ-GT, kao i stepena patohistološkog oštećenja 
jetre. Najniža BMDL5 u eksperimentu od 0,07228 mg BDE-
209/kg jetre, koja koreliše sa eksternom dozom od 39 mg/kg 
tm/dan izračunata je za aktivnost AST i ukazuje na to da je 
aktivnost AST ujedno i najosetljiviji biomarker hepatotoksič-
nosti BDE-209 kod subakutno eksponovanih pacova. Zak-
ljučak. Rezultati prezentovane studije daju doprinos pitanju 
toksikološkog profila BDE-209 sa fokusom na odnos između 
interne doze i hepatotoksičnih efekata. Kritična interna doza 
za efekat na AST od 0,07 mg/kg jetre, koja koreliše sa ekster-
nom dozom od 39 mg/kg tm/dan, jeste ujedno i najniža kri-
tična doza do sada definisana za hepatotoksične efekte BDE-
209. Kritičan efekat koji se bazira na dozi u ciljnom tkivu u 
većini slučajeva može se smatrati preciznije definisanim od 
kritičnog efekta definisanog na bazi oralno primenjene doze, 
naročito za nedegradabilne supstance sa niskim stepenom ap-
sorpcije, kao što je BDE-209. 
 
Ključne reči: 
difeniletri, halogenovani; jetra; toksičnost, testovi; 
pacovi. 
 
Introduction 
Polybrominated diphenyl ethers (PBDEs) are conside-
red to be extremely efficient flame retardants 1, 2. Decabro-
minated diphenyl ether (BDE-209) is a major component of 
deca-BDE commercial mixture 3–6 that can migrate from 
the product, get into the environment and pose a risk for the 
human health. The main source of exposure to BDE-209 is 
from the diet, however inhaled air could also contribute to 
its entire body burden 7, 8. After entering the organism, 
BDE-209 exhibits its toxic effects partly through the aryl 
hydrocarbon (Ah) receptor and consequent induction of he-
patic microsomal enzymes. It may also induce production 
of reactive oxygen species 7 found to be related to DNA 
damage. Based on numerous studies 8–17 on animals, the 
most prominent toxic effects of PBDEs are observed in the 
liver, thyroid hormone homeostasis, reproductive and ner-
vous systems.  
While the liver is one of the main target organs of its 
toxicity, the aim of this study was to assess the 
hepatotoxic effect of BDE-209 in the subacutely orally 
exposed Wistar rats. Considering that BDE-209 has poor 
solubility the level of its absorption and the amount reac-
hing target tissues are difficult to predict. We assumed 
that the dose measured at target site is more appropriate 
than orally given dose, allowing us to more accurately 
perceive the liver changes from the relationship of inter-
nal dose and intensity of effects. Evaluation of 
hepatotoxic effects was based on serum liver enzymes 
activity: aspartat aminotransferase (AST), alanine aminot-
ransferase (ALT), γ-glutamyl transferase (γ-GT), alkaline 
phosphatase (ALP), degree of histopathological changes, 
as well as oxidative stress parameters in liver homogena-
tes: malondialdehyde (MDA), activity of total superoxide 
dismutase (SOD) and content of sulfhydryl (-SH) groups. 
Methods 
Chemicals  
BDE-209, 98% (Sigma-Aldrich, St. Louis, MA, SAD) 
and dimethyl sulfoxide (DMSO) (Sigma-Aldrich, St. Louis, 
MA, SAD) were purchased from commercial sources.  
Experimental animals 
Male albino Wistar rats, weighing 200 g to 240 g were 
obtained from a disease-free stock bred at the Military Medi-
cal Academy in Belgrade, Serbia. The animals were housed 
in plastic cages with wire mesh top, in a climate-controlled 
facility with a constant 12-hour day and night cycle at 20°C 
to 24°C and relative humidity between 40% and 60%. The 
animals had free access to food and water throughout the 
study and were treated according to the guidelines for animal 
studies (No. 9667-1/2011), issued by the Academy’s Ethical 
Committee.  
 
Experimental protocol 
 
After a quarantine period of 14 days, each group of ani-
mals (n = 8 per group) was receiving treatment solution by ga-
vage in a volume of 0.5 mL/kg body weight (bw) day for 28 
days. Control animals were receiving water (the control gro-
up), while rats in the vehicle control group were receiving 
DMSO alone the (DMSO group). Three groups were receiving 
BDE-209 as a suspension in DMSO in the doses of 1,000, 
2,000, or 4,000 mg/kg bw/day (groups assigned as: BDE-
2091000, BDE-2092000, and BDE-2094000, respectively). The do-
ses of BDE-209 were chosen based on literature data 18, 19.  
Bws, water and food intake were recorded weekly. Clinical 
signs of poisoning were observed each day of the experiment. 
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After the period of exposure, animals were sacrificed, and 
samples of blood and liver were taken. Liver weight and ob-
served morphological changes were recorded immediately. 
Liver enzyme activity was measured in serum samples. Sam-
ples of the liver were taken for histopathological analysis as 
well as for homogenisation, and these samples were stored at -
80°C prior to the analysis of the oxidative stress parameters. 
The rest of the liver had been stored at -20°C  before the 
analysis of BDE-209 concentration could be performed.   
 
Determination of BDE-209 in liver 
 
The method was based on multistep extraction from 
homogenised liver, extract cleaning and determination of 
BDE-209 by gas chromatography (GC) – electron capture 
detection (GC – ECD) and GC – mass spectrometry (MS).  
Homogenised sample of 0.5–2 g was dried and fragmented 
into fine powder and transferred in a glass centrifuge tube. A 
total of 8 mL of mixture n-hexane:dichlormethane [(8:2; 
(V/V)] was added to the powder, and the total amount was 
vortexed, sonificated and centrifuged. Supernatant was sepa-
rated, dried in air flow and than resolved in 5 mL of 
acetonytrile. Further cleaning of sample was done using 
QuEChERSs (Quick Easy Cheap Effective Rugged Safe) 
(ENVIRO-CLEAN r EUMIV50CT, amchro GmbH, Hatters-
heim, Germany). After shaking, the content was centrifuged 
and aliquot was transfered into the tube for solvent evapora-
tion. The dried residue was reconstituted in 1 mL of n-
hexane and injected in GC. The retention time (Rt) and mass 
spectra (m/z values) were used for determination, and the pik 
area was used for quantification. Quality control of the 
analytical method was performed using certified reference 
material CIL-EDF-2524 Clean Fish (slurry) - Organic con-
taminants (LGC standards).  
 
Determination of liver enzymes activities 
 
Activity of AST, ALT, γ GT, and ALP in serum sam-
ples was determined on automatic analyser using commercial 
tests (Roche Elecsys 2010-cobas c 111 analyser, Roche Dia-
gnostics, Mannheim, Germany).  
 
Histopathological analysis of liver tissue 
 
The liver sample was excised and fixed with 10% neut-
ral formaldehyde. Dehydratation of tissue samples was done 
with graded aethanol and embedded in paraffin blocks. For 
semiquantitative tissue analysis, sections in 2 μm thick paraf-
fin were stained by hematoxylin and eosin (HE) method and 
analyzed (Olympus-2 microscope).  
Following criteria were used for semiquantitative eva-
luation of histopathological changes: 0 – unchanged liver`s 
parenchyma; 1 – single cells with intracellular oedema, va-
sodilatation of blood vessels and the appearance of 
inflammatory response cell; 2 – groups of cells with 
cytoplasmic vacuolation, distinct vasodilatation of numerous 
blood vessels (over 50%) and the accumulation of cellular 
infiltrate in the surrounding tissue; 3 – most cells with pro-
minent vascular degeneration and karyopyknosis, focal ac-
cumulation of cellular infiltrate, 4 – vacuolar degeneration 
and karyolysis in all cells, single cell necrosis and diffuse 
accumulation of cell infiltrate, and 5 – massive and diffuse 
necrosis, foam cells and tissue degeneration. For determine 
these parameters, whole longitudinal and cross-sectional 
tissue was analysed and observed under high magnification 
(40).  
 
Determination of oxidative stress parameters 
 
Oxidative stress parameters were measured after homo-
genisation of liver samples in saccharose medium. Following 
parametres were determined: concentration of MDA, activity 
of SOD and concentration of -SH groups. Proteins were me-
asured in homogentes by Bradford 20 method.  
The level of MDA in liver homogenates was based on 
reaction of MDA with thiobarbituric acid under acidic condi-
tion for 15 min at 95°C in termostatic water bath. In this re-
action light yellow to pink colour complexes were formed 
depending on the concentration of MDA in tissue homogena-
tes. Intensity of colour was measured at 523 nm and 600 nm. 
Activity of SOD, EC 1.15.1.1. in homogenates was me-
asured using the method of Misra and Fridovich 21, based on 
ability of SOD to inhibit spontaneous autooxidation of adre-
naline under alkaline condition (pH 10.2).  
The total content of -SH groups in liver homogenates 
was determined by the Ellman’s 22 method which is based on 
the reaction of 2,2-dinitro-5,5-dithio-benzoic acid (DTNB) 
with alifatic thiol compounds in alkaline condition (pH 9.0).  
 
Statistical analysis 
 
A significance of the difference among the data in the 
groups for certain effect was determined by analysis of va-
riance (ANOVA) and post-hoc Tukey test (p < 0.05) (Stati-
stica 7.0).  
PROAST software was used (RIVM, Bilthoven, Net-
herland) for the determination of dose-response relations-
hip and calculation of benchmark dose lower confidence 
limit [(BMDL i.e. BMDL5 if 5% of change in effect was 
considered as critical effect size – (CES)]. Moreover, asso-
ciated benchmark dose to critical dose was assigned as cri-
tical effect dose (CED) 23–25.  
Correlation analysis was used to estimate the relation-
ship between external and internal dose (p < 0.05). The 
following equation was derived: internal dose [mg BDE-
209/kg of liver wet weight (ww) = 0.0002  external dose 
(mg/kg bw/day) + 0.0622 
Results 
In life toxicology 
During the study period no clinical signs of poisoning 
were observed. Water consumption during the period of 
exposure decreased after the first week (Figure 1) and at 
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the end of study was significantly lower in rats treated with 
medium and the highest dose of BDE-209 (Table 1). 
During the experiment there were no significant chan-
ges in food intake related to DMSO group (Figure 1).   
Animals body weights were increasing during the peri-
od of exposure, but statistically significant differences in 
weight gain were not observed (Figure 2). 
After the application of 1,000, 2,000 or 4,000 mg BDE-
209/kg/day, the concentrations of BDE-209, measured in the 
liver, were 0.269, 0.569 and 0.859 mg/kg of the liver ww, 
respectively. In the control and the DMSO group concentrati-
ons of BDE-209 were below the quantification limit. 
The lowest concentration of BDE-209 in the liver of 
Wistar rats, resulted in a significant increase in relative li-
ver weight comparing to the control, while two highest 
concentrations, resulted in a significant decrease in relative 
liver weight compared to the results recorded in the DMSO 
group (Table 1). Relative liver weight was uniformly chan-
ging in the dose dependant manner, and calculated BMD5 
for internal dose of BDE-209 was 0.224 mg/kg of liver ww, 
corresponding to external dose of 971.4 mg BDE-
209/kg/day (Table 1).  
Fig. 1 – Weekly records on water and food intake in Wistar rats subacutely exposed to decabrominated diphenyl ether 
(BDE-209); DMSO – dimethyl sulfoxide. 
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Table 1 
Influence of increasing doses of decabrominated diphenylether on liver weight, relative liver weight, and 
water and food intake in subacutely exposed Wistar rats 
Internal dose (mg/kg )/ Liver weight (g) Relative liver  
Dose (mg/kg bw/day) weight (%) 
Water intake§ 
(g) 
Food intake§ 
(g) 
0/0 control      2.72 ± 0.26        73.25 ± 5.32       40.75 ± 4.50 
0/0 DMSO     3.63* ± 0.37       53.00 ± 14.61      30.00 ± 8.89 
0.269/1000     3.44* ± 0.29        44.69 ± 10.28     22.81* ± 3.29 
0.569/2000    2.75# ± 0.16       41.68* ± 16.02     25.00* ± 5.47 
0.859/4000 
8.50 ± 0.38 
9.11 ± 0.77 
10.93 ± 1.21 
8.39 ± 0.83 
6.90 ± 1.02   2.38# ± 0.24       43.78* ± 4.15     27.08* ± 1.58 
 Results on benchmark dose and model internal dose / external dose 
BMD/BMDL nt <10 / <10 - - 
dose response nt (+) / (+) (-) (-) 
Model nt E3 / E5 - - 
BMD5 nt 0.2244 / 971.4 - - 
* – A statistically significant difference from the control group; # – A statistically significant difference from the DMSO group 
(ANOVA, post-hoc Tukey test); § – Average obtained from 4 measurements, recorded weekly, during the 4-week of 
experiment; nt – dose response relationship was not tested; (+) or (-) – dose response relationship confirmed or not confirmed; 
E1-E5 – type of dose-response model given by PROAST software; BMD – benchmark dose; BMDL – 95% lower confidence 
limit of BMD; DMSO – dimethyl sulfoxide. 
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Fig. 2 – Daily records (Records were made five times a week) on body weight (g) of Wistar rats subacutely exposed to  
decabromineted diphenyl ether (BDE-209); DMSO – dimethyl sulfoxide. 
Liver enzymes 
 
As for the results of liver enzyme activity, a signifi-
cant increase of the AST was induced by the medium and 
the highest concentrations, while a significant increase of γ-
GT was induces by the lowest and the highest liver BDE-
209 concentrations (Table 2). 
The dose-response relationship was confirmed only for 
these two effects on liver enzymes. For the effect on AST, cal-
culated BMDL5 was 0.07228 mg BDE-209/kg of liver ww and 
Table 2  
Influence of increasing doses of decabrominated diphenylether on serum liver enzyme activity of subacutely 
exposed Wistar rats 
Internal dose (mg/kg )/ 
dose (mg/kg bw/day) 
AST 
(U/L) 
ALT 
(U/L) 
ALP 
(U/L) 
γ-GT 
(U/L) 
0/0 control     211.0 ± 47.9   76.3 ± 21.2  295.5 ± 27.3 2.2 ± 1.0 
0/0 DMSO     221.0 ± 15.6   61.3 ± 4.11 173.5* ± 54.8 1.8 ± 0.5 
0.269/1000     218.1 ± 17.4   63.4 ± 5.7   250.0 ± 37.7 4.9*,# ± 1.1 
0.569/2000   330.0* ± 73.0   85.2 ± 22.7   166.0 ± 48.9 2.0 ± 1.3 
0.859/4000   295.2* ± 33.9   72.2 ± 10.8   184.8 ± 31.4 4.4*,# ± 2.3 
 Results on benchmark dose and model internal dose / external dose 
BMD/BMDL <10 / - - / - - / - - / - 
dose response (+) / (-) (-) / (-) (-) / (-) (+) / (+) 
Model E2 / - - / - - / - E1 / E1 
BMD5 0.07228/ - - / - - / - - / - 
* – A statistically significant difference from the control group; # – A statistically significant difference from the 
dimethyl sulfoxide (DMSO) group (ANOVA, post-hoc Tukey test); (+) or (-) – dose-response relationship confirmed or 
not confirmed; E1-E5 – type of dose-response model given by PROAST software; BMD – benchmark dose; BMDL – 
lower confidence limit of BMD; AST – aspartat aminotransferase; ALT –alanine aminotransferase; ALT – alanine 
aminotransferase; ALP –    alkaline phosphatase; γ-GT – gamma glutamyl tranferase. 
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Fig. 3 – Dose-response curve for the effect on aspartat amino transferase (AST) activity against liver concentrations of 
decabromineted diphenyl ether (BDE-209); CED – critical effect dose. 
 
 
                                           A) Control group 
 
      B) Dimethyl sulfoxide group 
 
C) 0.269 mg BDE-209/kg liver 
the curve representing the target tissue dose-response relations-
hip is shown in Figure 3. The dose of 0.07228 mg BDE-209/kg 
of liver ww, corresponding to external dose of 39 mg/kg/day, 
was the lowest BMDL5 among all the calculated benchmark do-
ses indicating the effect on AST as the most sensitive biomarker 
of BDE-209 hepatotoxicity in subacutely exposed rats. 
Histopathology 
Tissue sections of the rat liver from the control and the 
DMSO group did not show any deviation from the normal 
histological structure (Figure 4, A and B). 
With the lowest concentration of 0.269 mg/kg, normal 
histology of the liver was preserved only in the central parts. 
Edema of hepatocytes, mild hyperemia and small focal he-
morrhages in the sinusoids were observed. Sinusoids were 
slightly narrowed because the moderate edema of the most 
hepatocytes. Cytoplasm was very eosinophilic and filled with 
small vacuoles. Nucleus in these cells were rounded, irregu-
lar and hyperchromatic, and nucleoli were difficult to be ob-
served (Figure 4C). Numerous pathological mitoses were 
present, in most hepatocytes, particularly in the group where 
internal dose of BDE-209 was 0.569 mg/kg of liver ww (Fi-
gure 4D). All blood vessels were dilated, with moderate to 
severe polymorphonuclear cell infiltration (Figure 4E). A re-
sponse higher than 10% was considered as extra risk for the 
degree of histopathological changes and therefore BMDL10 
was calculated. The values of the degree of histological da-
mage as ordinal type of the variable were converted in 
quantal type of the variable 23, 24. Dose response was confir-
 
D) 0.569 mg BDE-209/kg  liver 
 
E) 0.859 mg BDE-209/kg  liver 
Fig. 4 – Histopathological changes in the liver induced by decabromineted diphenyl ether (BDE-209) after 28 days oral exposure; (HE, 40): A) 
a – radially placed hepatocytes, b – unchanged hepatocyte;  B) a – no histological lesions found, b – hepatocytes in different phases of mitosis; 
C) a – small number of polymorphonuclears around dilated blood vessel, b – local bleedings in sinusoids; D) a – moderate focal bleeding, b – 
pathological mitosis of hepatocytes; E) a – discontinuity of vascular wall, b – different phases of hepatocytes degenartion. 
Ćurčić M. et al. Vojnosanit Pregl 2015; 72 (5): 405–413. 
Vol. 72, No. 5 VOJNOSANITETSKI PREGLED Page 411 
med for either internal or external dose of BDE-209 and cor-
responding BMDL10 doses were 0.324 mg BDE-209/kg of 
liver ww and 812 mg/kg bw/day, respectively. 
 
Oxidative stress parameters 
 
A significant influence of BDE-209 on oxidative stress 
parameters, MDA, SOD, -SH, in liver homogenates was not 
confirmed, however internal dose-response relationship was 
confirmed as a linear model assigned as E1 according to 
PROAST software (Table 3).  
Table 3  
Influence of increasing doses of decabrominated diphenylether on oxidative stress parameters in liver homogenates of 
subacutely exposed Wistar rats 
Internal dose (mg/kg )/ 
dose (mg/kg bw/day) 
MDA 
(nmol/mg of 
 proteins) 
-SH groups 
(nmol/mg of  
proteins) 
SOD 
(U/g of proteins) 
0/0 control  108.71 ± 47.77    29.47 ± 8.92     103.03 ± 43.64 
0/0 DMSO  127.44 ± 44.01    26.94 ± 14.23     102.75 ± 40.56 
0.269/1000   90.91 ± 39.93    27.40 ± 12.94    100.88 ± 21.43 
0.569/2000  114.84 ± 57.04    25.40 ± 9.99    100.50 ± 21.77 
0.859/4000  161.99 ± 82.12    27.86 ± 3.70    97.69 ± 18.05 
 Results on benchmark dose and model internal dose / external dose 
BMD/BMDL - / - - / - - / - 
dose response (+) / (+) (+) / (+) (+) / (+) 
Model E1 / E1 E1 / E1 E1 / E1 
BMD5 - / - - / - - / - 
ANOVA with post-hoc Tukey test was used for statistical analysis; (+) or (-) – dose-response relationship confirmed 
or not confirmed; E1-E5 – type of dose-response model given by PROAST software; MDA – malondialdehyde;  
SH – sulfhydryl; SOD – superoxide dismutase; BMD – benchmark dose; BMDL – lower confidence limit of BMD. 
 
Discussion 
Determining the relation between external and internal 
doses, and measurements of BDE-209 concentrations in the 
liver show that the ratio among the external doses (1 : 2 : 4) 
is different from the ratio among internal doses (1 : 2 : 3.5), 
implying the lower absorption when the highest dose is ap-
plied. Internal doses correlate with external ones (r = 0.972; 
p < 0.05) according to the equation: internal dose (mg BDE-
209/kg of liver ww) = 0.0002  external dose (mg/kg 
bw/day) + 0.0622. Hepatotoxicity is demonstrated based on 
significant increase in AST and γ-GT activities, while the 
lowest BMDL5 is calculated for the serum AST activity. The 
value of 0.07228 mg BDE-209/kg of liver ww, correspon-
ding to external dose of 39 mg/kg/day, indicates the increase 
of AST activity as the most sensitive biomarker of BDE-209 
hepatotoxicity in subacutely exposed rats. The degree of his-
tological damage increases in the dose-dependent manner, 
and the corresponding BMDL10 dose is 0.324 mg BDE-
209/kg of the liver.  
For decaBDE the United States Environmental Protec-
tion Agency provides no observed adverse effect level (NO-
AEL) dose of 2.22 mg/kg bw/day as a reference point, 
however this dose is related with neurobehavioral effects 26–28. 
As for the liver, in a 2-year long NTP study (1986), male and 
female B6C3F1 mice, administered decaBDE in the diet at 
the doses of 0,3200 or 6,650 mg/kg bw/day for males and 
0,3760 or 7,780 mg/kg bw/day for females, the following ef-
fects were recorded: liver granulomas and liver hypertrophy 
in males. Based on these results no NOAEL for liver effects 
is derived. However, the study identifies a NOAEL for a por-
tal-of-entry effect for females of 3760 mg/kg bw/day 29. The 
data sets from another NTP (1986) 2-year rat and mouse stu-
dies are selected for BMD modeling: thrombosis in the liver, 
liver degeneration, in male rats and centrilobular hypertrophy 
in livers of male mice. The lowest calculated BMDL10 was 
406 mg/kg bw/day for liver degeneration effect in male 
rats 29. Only in one study internal dose, in site, was used for 
the assessment of BDE-209 subacute oral toxicity in rats 30. 
In this experiment internal doses arround 0.25 mg/kg of liver 
ww induced slight centrilobular hypertrophy in the liver together 
with increased expression of hepatic CYP1A and CYP2B 
(BMDLs10 0.5–0.7 mg/kg bw/day) and dose-dependent decrease 
in serum ALP (BMDL10 0.6 mg/kg bw/day, corresponding to 
0.222 mg/kg of liver ww). Histopathological changes seen in 
our experiment started from the concentration of 0.269 mg/kg of 
liver ww, which is very close to the value published by Van der 
Ven et al. 30. Hepatotoxicity of BDE-209 either in vivo or in vit-
ro is usually connected with: a) the increased formation of reac-
tive oxygen species, oxidative stress and decreased efficacy of 
antioxidative defence system 7, 31–34; induction of apoptosis rela-
ted with oxidative stress in human hepatoma cells HepG2 33; 
aryl hydrocarbon receptor (AhR) binding particularly expression 
of luciferase reporter gene mediated by AhR in H4II hepatoma 
cell line 5; induction of CYP1A1 mRNA and CYP1A1 protein 
mediated by AhR 5, 30. The lack of effect on oxidative stress pa-
rameters in our experiment can be understood from the differen-
ces, since the values were measured at the end of exposure in 
which activation of adaptive mechanisms of enzyme or non-
enzyme antioxidative defense could take place 35.  
Conclusion 
The results of the present work add up to the issue of deca-
brominated diphenyl ether toxicity profile with a focus on the re-
lationship between internal dose and hepatotoxicity. Critical in-
ternal dose for the effect on AST of 0.07 mg/kg of liver ww, 
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corresponding to external dose of 39 mg/kg/day in our study is 
the lowest dose ever observed in the studies on decabromina-
ted diphenyl ether hepatotoxicity indicating the increase of 
AST activity as the most sensitive biomarker of decabromina-
ted diphenyl ether hepatotoxicity in subacutely exposed rats. 
Critical effect based on internal dose in the majority of cases is 
considered as more precisely defined than the effect establis-
hed based on external dose, particularly for the persistent sub-
stances with low absorption rate, such as decabrominated 
diphenyl ether.  
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